Volume 14, Number 2—February 2008
Dispatch
Methicillin-Resistant Staphylococcus aureus, Geneva, Switzerland, 1993–2005
Patrice Francois*1
, Stephan Harbarth*1, Antoine Huyghe*, Gesuele Renzi*, Manuela Bento*, Alain Gervaix*, Didier Pittet*, and Jacques Schrenzel*
, Stephan Harbarth*1, Antoine Huyghe*, Gesuele Renzi*, Manuela Bento*, Alain Gervaix*, Didier Pittet*, and Jacques Schrenzel*
Table 1
Demographic characteristics, types of infection, and epidemiologic profiles of 61 patients with CA-MRSA colonization or infection, Geneva University Hospitals, 2002–2005*
| Characteristic | Value |
|---|---|
| Demographic data | |
| Mean ± SD age, y | 33 ± 21 |
| Male | 35 (57) |
| Immigrant, foreign origin or residency outside Switzerland | 25 (41) |
| Recent history of travel before CA-MRSA isolation | 29 (48) |
| Institutionalized (prison, nursing home, asylum-seeker camp) | 11 (18) |
| Healthcare worker |
4 (7) |
| Type of infection/colonization | |
| Primary cutaneous abscess or pyoderma | 27 (44) |
| Wound infection | 4 (7) |
| Impetigo | 3 (5) |
| Other | 1 (2) |
| Colonization |
26 (43) |
| Site of skin infection (n = 27) | |
| Head and face | 6 |
| Upper extremity | 6 |
| Trunk and buttock | 7 |
| Lower extremity |
8 |
| Other clinical features | |
| Presence of >1 other medical condition | 16 (26) |
| Previous exposure (<6 mo) to antimicrobial drug | 16 (26) |
| Case-fatality mortality rate | 0 |
*Values are no. (%) of patients unless otherwise indicated. For 2 patients, no microbiologic specimen was available for molecular characterization. See also supplementary material (available from www.genomic.ch/sup6.php). CA-MRSA, community-associated methicillin-resistant Staphylococcus aureus.
Page created: July 07, 2010
Page updated: July 07, 2010
Page reviewed: July 07, 2010
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.